Article (Scientific journals)
Regulated IRE1α-dependent decay (RIDD)-mediated reprograming of lipid metabolism in cancer.
Almanza, Aitor; Mnich, Katarzyna; Blomme, Arnaud et al.
2022In Nature Communications, 13 (1), p. 2493
Peer Reviewed verified by ORBi
 

Files


Full Text
41467_2022_Article_30159.pdf
Author postprint (2.35 MB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
RNA, Messenger; Transcription Factors; X-Box Binding Protein 1; ERN1 protein, human; Protein Serine-Threonine Kinases; Endoribonucleases; Endoplasmic Reticulum Stress/genetics; Humans; RNA, Messenger/metabolism; Transcription Factors/metabolism; X-Box Binding Protein 1/genetics; X-Box Binding Protein 1/metabolism; Endoribonucleases/genetics; Endoribonucleases/metabolism; Lipid Metabolism/genetics; Neoplasms; Protein Serine-Threonine Kinases/genetics; Chemistry (all); Biochemistry, Genetics and Molecular Biology (all); Physics and Astronomy (all); General Physics and Astronomy; General Biochemistry, Genetics and Molecular Biology; General Chemistry
Abstract :
[en] IRE1α is constitutively active in several cancers and can contribute to cancer progression. Activated IRE1α cleaves XBP1 mRNA, a key step in production of the transcription factor XBP1s. In addition, IRE1α cleaves select mRNAs through regulated IRE1α-dependent decay (RIDD). Accumulating evidence implicates IRE1α in the regulation of lipid metabolism. However, the roles of XBP1s and RIDD in this process remain ill-defined. In this study, transcriptome and lipidome profiling of triple negative breast cancer cells subjected to pharmacological inhibition of IRE1α reveals changes in lipid metabolism genes associated with accumulation of triacylglycerols (TAGs). We identify DGAT2 mRNA, encoding the rate-limiting enzyme in TAG biosynthesis, as a RIDD target. Inhibition of IRE1α, leads to DGAT2-dependent accumulation of TAGs in lipid droplets and sensitizes cells to nutritional stress, which is rescued by treatment with the DGAT2 inhibitor PF-06424439. Our results highlight the importance of IRE1α RIDD activity in reprograming cellular lipid metabolism.
Disciplines :
Biochemistry, biophysics & molecular biology
Author, co-author :
Almanza, Aitor ;  Apoptosis Research Centre, National University of Ireland, Galway, H91 W2TY, Ireland ; School of Biological and Chemical Sciences, National University of Ireland, Galway, H91 W2TY, Ireland
Mnich, Katarzyna  ;  Apoptosis Research Centre, National University of Ireland, Galway, H91 W2TY, Ireland ; School of Biological and Chemical Sciences, National University of Ireland, Galway, H91 W2TY, Ireland
Blomme, Arnaud  ;  Université de Liège - ULiège > Département de pharmacie ; CRUK Beatson Institute, Garscube Estate, Switchback Road, Glasgow, G61 1BD, UK
Robinson, Claire M;  Apoptosis Research Centre, National University of Ireland, Galway, H91 W2TY, Ireland ; School of Biological and Chemical Sciences, National University of Ireland, Galway, H91 W2TY, Ireland
Rodriguez-Blanco, Giovanny ;  CRUK Beatson Institute, Garscube Estate, Switchback Road, Glasgow, G61 1BD, UK
Kierszniowska, Sylwia;  metaSysX GmbH, 14476, PotsdGarscube Estateam-Golm, Germany
McGrath, Eoghan P;  Apoptosis Research Centre, National University of Ireland, Galway, H91 W2TY, Ireland ; School of Biological and Chemical Sciences, National University of Ireland, Galway, H91 W2TY, Ireland
Le Gallo, Matthieu;  Inserm U1242, University of Rennes, Rennes, France ; Centre de lutte contre le cancer Eugène Marquis, Rennes, France
Pilalis, Eleftherios ;  e-NIOS Applications PC, 25 Alexandros Pantou str., 17671, Kallithea, Greece
Swinnen, Johannes V ;  Department of Oncology, Laboratory of Lipid Metabolism and Cancer, KU Leuven Cancer Institute, Leuven, Belgium
Chatziioannou, Aristotelis;  e-NIOS Applications PC, 25 Alexandros Pantou str., 17671, Kallithea, Greece ; Center of Systems Biology, Biomedical Research Foundation of the Academy of Athens, 4 Soranou Ephessiou str, 11527, Athens, GR, Greece
Chevet, Eric ;  Inserm U1242, University of Rennes, Rennes, France ; Centre de lutte contre le cancer Eugène Marquis, Rennes, France
Gorman, Adrienne M ;  Apoptosis Research Centre, National University of Ireland, Galway, H91 W2TY, Ireland ; School of Biological and Chemical Sciences, National University of Ireland, Galway, H91 W2TY, Ireland
Samali, Afshin ;  Apoptosis Research Centre, National University of Ireland, Galway, H91 W2TY, Ireland. afshin.samali@nuigalway.ie ; School of Biological and Chemical Sciences, National University of Ireland, Galway, H91 W2TY, Ireland. afshin.samali@nuigalway.ie
More authors (4 more) Less
 These authors have contributed equally to this work.
Language :
English
Title :
Regulated IRE1α-dependent decay (RIDD)-mediated reprograming of lipid metabolism in cancer.
Publication date :
06 May 2022
Journal title :
Nature Communications
eISSN :
2041-1723
Publisher :
Nature Research, England
Volume :
13
Issue :
1
Pages :
2493
Peer reviewed :
Peer Reviewed verified by ORBi
Funders :
Science Foundation Ireland
Funding text :
This study utilized NUI Galway Genomics and Screening Core Facility, which is supported by funds from NUI Galway, Science Foundation Ireland, the Irish Government’s Program for Research in Third Level Institutions, Cycle 5 and the European Regional Development Fund. We also would like to thank the Metabolomics unit of the Cancer Research UK Beatson Institute, with particular thanks to Dr. David Sumpton. This work was funded by Precision Oncology Ireland, which is part-funded by the Science Foundation Ireland (SFI) Strategic Partnership Program (grant number 18/SPP/3522), EU H2020 MSCA RISE-734749 (INSPIRED), EU H2020 MSCA ITN-675448 (TRAIN-ERS) to A.M.G. and A.S., SFI Industry Fellowship to K.M. (18/IF/6247). We are grateful to the contributions of all our team members, in particular Dr. Shane Deegan, Dr. Brian Leuzzi, Dr. Mark Harvey, Xara Mastrokalou, and Bianca Pasat.This study utilized NUI Galway Genomics and Screening Core Facility, which is supported by funds from NUI Galway, Science Foundation Ireland, the Irish Government’s Program for Research in Third Level Institutions, Cycle 5 and the European Regional Development Fund. We also would like to thank the Metabolomics unit of the Cancer Research UK Beatson Institute, with particular thanks to Dr. David Sumpton. This work was funded by Precision Oncology Ireland, which is part-funded by the Science Foundation Ireland (SFI) Strategic Partnership Program (grant number 18/SPP/3522), EU H2020 MSCA RISE-734749 (INSPIRED), EU H2020 MSCA ITN-675448 (TRAIN-ERS) to A.M.G. and A.S., SFI Industry Fellowship to K.M. (18/IF/6247). We are grateful to the contributions of all our team members, in particular Dr. Shane Deegan, Dr. Brian Leuzzi, Dr. Mark Harvey, Xara Mastrokalou, and Bianca Pasat.
Available on ORBi :
since 18 May 2022

Statistics


Number of views
88 (4 by ULiège)
Number of downloads
36 (2 by ULiège)

Scopus citations®
 
40
Scopus citations®
without self-citations
38
OpenCitations
 
7
OpenAlex citations
 
45

Bibliography


Similar publications



Contact ORBi